Monday, September 14, 2026

White House Tariff Message: Trump Says Companies Are Fleeing Mexico and Europe, as U.S. Steel Tops Japan After 26 Years

The U.S. surpasses Japan in steel production for the first time in 26 years, attributed to tariffs and Trump's policies.

AMD’s AI Chip Sales Soar, But Still Lag Behind Nvidia’s Dominance

AMD's AI data center chip sales soared 94% to $12.6 billion, but still lag behind Nvidia's dominance in the AI semiconductor market.

Shocking Betrayal: Chinese Military Leader Leaks Nuclear Secrets to the U.S. – What It Means for China?

A high-ranking Chinese military official allegedly passed nuclear secrets to the U.S., causing major upheaval in Beijing's elite circles.

Tag: Yuflyma

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us